Cell BioEngines, Inc., is a clinical-stage biotech company focused on curing cancer by developing human cells as ‘off-the-shelf’ drugs. The company leverages its proprietary Stem-SPACE™ platform technology to produce clinical grade cells at economies of scale by harnessing the incredible potential of healthy umbilical cord blood as a unique starting material.